Cyclica (acquired by Recursion, Nasdaq: RXRX)
Biotechnology ResearchOntario, Canada51-200 Employees
Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter.
Innovative Content Platform Cyclica, now part of Recursion, operates within the biotechnology research sector with a focus on leveraging AI and advanced technology. Their recent launch of Beacons for Brands, an AI platform for content creators and brands, indicates a growing interest in digital monetization tools, presenting opportunities for partnerships in AI-driven marketing and content monetization solutions.
Strong Market Position Beacons AI has secured a seed funding of $6 million and has achieved revenue between 1 million to 10 million dollars, demonstrating solid market traction. This financial stability and growth potential make them an attractive prospect for enterprise software, SaaS integrations, and additional funding collaborations.
Competitive Landscape The company faces competition from emerging platforms like Linkpop, launched by Shopify to rival Beacons.ai. Identifying joint ventures or integrations with complementary social commerce tools could open channels for expanding user engagement and monetization offerings.
Technological Engagement Cyclica's utilization of a diverse tech stack including Profitwell, CDNjs, Chargebee, and social media integrations suggests a focus on scalable, user-centric digital solutions. Providing complementary SaaS products or APIs that enhance content monetization and audience growth could align well with their technological roadmap.
Growth & Partnerships The recent launch of Beacons for Brands and the company's continuous innovation suggest an openness to strategic alliances with content creators, brands, and tech providers. Tailored partnership opportunities in AI, marketing automation, or social commerce could support their expansion goals and facilitate mutual growth.
Cyclica (acquired by Recursion, Nasdaq: RXRX) uses 8 technology products and services including Profitwell, cdnjs, Canny, and more. Explore Cyclica (acquired by Recursion, Nasdaq: RXRX)'s tech stack below.
| Cyclica (acquired by Recursion, Nasdaq: RXRX) Email Formats | Percentage |
| First.Last@cyclicarx.com | 100% |
| First@beacons.ai | 86% |
| Last@beacons.ai | 13% |
| FirstL@beacons.ai | 1% |
Biotechnology ResearchOntario, Canada51-200 Employees
Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter.
Cyclica (acquired by Recursion, Nasdaq: RXRX) has raised a total of $6M of funding over 1 rounds. .
Cyclica (acquired by Recursion, Nasdaq: RXRX)'s revenue is estimated to be in the range of $1M$10M
Cyclica (acquired by Recursion, Nasdaq: RXRX) has raised a total of $6M of funding over 1 rounds. .
Cyclica (acquired by Recursion, Nasdaq: RXRX)'s revenue is estimated to be in the range of $1M$10M